7 i, Q' C- ?% F+ Z4 Y 0 _; p$ @- f: h3 S$ F 6 G. C4 k4 ]- y8 ^3 w' Q / y( k2 m |2 B6 n* k& L' o) p7 b# {2 h/ o( j
& G# x- ?/ Q7 _1 k
# J. a- K) S4 l, N [- }2 n5 I+ g. G6 q5 R8 X8 D' g* N! y
% I# o' ^" Z% S3 {2 J f+ t
0 K4 A8 E* J/ L' o5 P. QTentative Session # M8 G' q1 a) N( I1 JChina Classification and Variable Selection ' U" Y _8 t& ?2 v) a(Chair: Yang Li, Renmin University of China) ! c3 q, K" O5 o# P* z- F Clinical information data mining and application) Z6 A, ]$ E) ?
(Chair: Xiuhua Guo, Capital Medical University) ! \+ ^; a7 e& [" DJapan Missing Data in Clinical Trials: Basic Concepts and Practical Issues in Japan( m: l- C; c% [: u1 z4 \
(Chair: Hideki Suganami, Ph.D. Kowa Co., Ltd., Satoru Fukinbara, Ph.D. Ono Pharmaceutical Co., Ltd.) % ]( P6 Z% p# }, t* s% x & ~$ ^+ I) x8 f: z0 s Design and conduct of clinical trials for preventing missing data$ c0 e1 Q, r- e
(Speaker: Shiro Tanaka, Ph.D.Kyoto University) , N# S, z( C* s3 Q( ]! C0 M z+ C+ j Some examples of the treatment of missing data in investigator-initiated clinical trials5 y6 p- x! M' z) `3 ?! k0 c, l4 _
(Speaker: Yoichi M. Ito, Ph.D.Hokkaido University)* b9 Q$ b$ ?2 K$ N" k; E
Actual practice of handling of missing data in clinical trials * G0 p0 J; |1 J
(Speaker: Nobushige Matsuoka, Ph.D., Yoichi Ii, Ph.D., Tamotsu Yoshiyama, M.S., Norisuke Kawai, Ph.D. ,Clinical Statistics, Pfizer Japan Inc.)/ x8 g/ O; z/ i0 x* N* E# t
Survey results from JPMA member companies: Current approach for missing data in pivotal registration trials: V1 N" ^+ H& b# I5 [0 z
(Speaker: Satoru Tsuchiya, M.S. ,Biostatistics group, Data science Dainippon Sumitomo Pharma, Co., Ltd.): b- x$ W$ H$ M4 k
( V5 T7 q, z$ S 6 l0 }1 ]- m, s0 \% @ 2 {! n2 _- u! G `: c7 ` 9 V1 h7 J, a2 _7 l, Q% g1 E& MKorea4 e* Y) K8 z! J9 N* i. z# C
4 t" w. N6 b8 ^+ I$ |: L
& Z9 J/ i$ \4 {
; j% B1 t" C, h2 c' Y
5 N/ t; |' L$ Y4 M8 j
: T/ {1 k5 T; A3 \- j ( }- B3 S8 J7 Q2 t7 l5 QKorea Selected Topics in Biometrics study, f; A$ p; P: f
(Chair:Hyonggin An, Korea University) 4 w7 V/ _' T+ W% T- G8 l; C Identification of Variant Associated with Disease using Protein Structural Feature-based Prioritization 4 _+ ]/ {' V% X) D2 ]9 G) y(Speaker: Tae-Rim Lee,Korea National Open University,Min-Seok Kwon(Seoul National University),Sungho Won(Chung Ang University),Taesung Park(Seoul National University)) / |: ?$ e) o9 k) O) ]6 [' Z8 p) N 9 ]6 a. Z k6 H" C& Z
Differential Expression Detection in RNA-seq Data with a Small Number of Replicates & ?& X$ i) H" a, |) I# p(Speaker: Jungsoo Gim(Seoul National University), Taesung Park(Seoul National University)) 5 a6 R& ]1 V% Y: Q2 P/ { Investigation of Relationship between Influenza Occurrence and Climatic Factors in Three Major Regions in Korea using Time Series Analysis , z) B! f* ]' n. `% G(Speaker: Hyonggin An (Korea University College of Medicine)and Sang-A Cho (National Cancer Center in Korea))+ x3 j9 Y0 {/ U. `
Chair: Jinheum Kim, University of Suwon 8 Y( g$ `" X) n6 L1 S b; g
Additive Hazard Model with Additive Frailty for Semi-Competing Risks Data (Speaker: Yun-Nam Kim (Severance Hospital Clinical Trials Center), Chung Mo Nam(Yonsei University College of Medicine), Yang-Jin Kim(Sookkmyung Women’s University), and Jinheum Kim(University of Suwon)) " E5 o1 R V* E5 t& w3 i9 n0 i Variable Selection in Competing-Risks Frailty Models using Penalized H-likelihood5 X9 v+ B/ m# F2 a7 R s0 S
(Speaker: Do Ha (Daegu Haany University) and Youngjo Lee (Seoul National University))2 c8 x- t! ~1 P$ I1 N2 a' g, a
Gene-Gene Interaction Analysis with Survival Phenotype0 t" p' K l9 ]: ?
(Speaker: Seungyeon Lee (Sejong University), Jin-SeokOh(Sejong University), Min-Seok Kwon(Seoul National University), and Taesung Park(Seoul National University))" y' v0 n D% m& r: t( K
Maximally Selected Two-sample Gray Statistics with Competing Risks Data/ y/ P) O( ?: y3 B0 P' c
(Speaker: Jinheum Kim (University of Suwon), Sook-young Woo(Samsung Advanced Institute of Technology), Seonwoo Kim(Samsung Advanced Institute of Technology))( x, T, O8 o5 g$ V6 k- s
Singapore Session title: Likelihood based inference for complex models8 y( `+ {8 ~8 x& Z n
A multiple imputation method for longitudinal data with covariate measurement error under generalized partially linear mixed models- t( b# H5 a9 C
(Speaker: Xiang Liming(Nanyang Technological University)) 4 j1 J% `( Z* F6 n, w/ X& } Bayesian Empirical Likelihood 6 d8 \- J/ L1 L(Speaker: Sanjay Chaudhuri(National University of Singapore, Singapore)). `6 s! h9 Y: }4 X% V
Consistent Cross-Validation for Tuning Parameter Selection in High-Dimensional Variable Selection 2 [4 g2 A* ]( `- t) a- c3 k# H& c(Speaker: Yang Feng(Columbia University)) 9 W/ ^0 g& B a5 U$ U, U A sign based loss approach to model selection in nonparametric regression+ a- P4 S2 g+ i" j
(Speaker: Li Jialiang (National University of Singapore, Singapore)) , K' T! [( k; e7 o8 {' x* V4 u9 tThailand Meta analysis in Clinical Trials 0 q8 I+ U+ Q3 Z+ z. ^1 m Publication Bias and Sensitivity Analysis for Meta-Analysis of Multi-Arm Trials 2 u2 e/ C. C0 F! k) ~8 Y(Speaker: Dr. Hathaikan Chootrakool (Suan Dusit Rajabhat University)) 3 o1 _) j, g2 t8 Z1 d+ ~8 i7 p$ C Some New Tests for Homogeneity of Relative Risks in Meta-Analysis' N y `8 i+ @6 f9 j
(Speaker: Assoc. Prof. Dr. Chtwongkasemukiat Viwatwongkasem (Mahidol University)) 1 ?/ I7 k v A8 J0 d Application of Network Meta-analysis in Randomized Controlled Trials. F6 F' d, a* T1 R6 Z
(Speaker: Dr. Ammarin Thakkinstian(Ramathibodi Hospital, Mahidol University))% w8 }3 O$ ~8 @* `6 B2 E& l
6 W6 x5 e3 R( @/ c" ?. [% @; z# |8 N& w9 U/ X
8 y& u! F* W; h- T% D' T, ]& f. \
) |, q1 _. g3 ]! O
5 j- j9 x' O9 U K7 [1 _% E( Z
' r9 i2 A. q! n* [( `; ~/ O' g4 P `# }# P4 M
( C3 m/ a/ i8 v' O& k' a$ q8 ?9 X3 G7 d: [# Z1 V" z
( L/ D% z& z$ P" P2 K% \8 b; A: A" T% i) U& b% U
$ K p9 ]% H$ b